Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer : the JAVELIN Solid Tumor JPN trial

• Toshihiko Doi

• Satoru Iwasa

• Kei Muro

• Taroh Satoh

• Shuichi Hironaka

• Taito Esaki

• Tomohiro Nishina

• Hiroki Hara

• Nozomu Machida

• Yoshito Komatsu

• Yasuhiro Shimada

• Satoshi Otsu

• Shin Shimizu

• Morihiro Watanabe

Journal

• Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編]

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編] 22 (4), 817-827, 2019

  Tokyo : Springer Japan

Keywords

• PD-L1
• Gastric cancer
• Phase 1
• Japan
• Avelumab

Details

• CRID: 1523388080253275520
• NII Article ID: 40021926036
• NII Book ID: AA11316227
• ISSN: 14363291
• NDL BIB ID: 029757571
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I029757571
• Web Site: https://search.jamas.or.jp/link/ui/2020221918
• Text Lang: en
• NDL Source Classification:
  • ZS34(科学技術--医学--腫瘍・癌)
• Data Source:
  • NDL
  • CiNii Articles